Research institute
As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.
“It’s especially cruel when cancer affects such small children, so it is encouraging that this study offers some hope for very young patients and their families,” said Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London.
The study reveals that brain tumors in babies are molecularly unique and could be candidates for targeted treatments.
Results from the trial, which will begin dosing on April 6, aren’t likely until September.
Cobra Biologics and the Karolinska Institutet, secured millions in emergency funding from Horizon 2020 to support research and development and an eventual Phase I clinical trial testing of a DNA vaccine against COVID-19.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
PRESS RELEASES